Calabrese Consulting LLC’s Post

Marijuana Retailers Launch Round-Up Campaign to Fund Legalization Cannabis News: Learn about the latest developments in the Round-Up Campaign for cannabis legalization efforts. Read More At Leafyleaks. https://lnkd.in/eyyvCNu3

German Officials Under Pressure To Unveil Marijuana Legalization’s Second Step Focused On Commercial Sales Now that marijuana is legal in Germany, lawmakers are turning their attention to the planned “second pillar” of the reform: establishing a pilot program for commercial sales. And while the timeline for introducing the complementary legislation is unclear, one key lawmaker says she’s hoping to see a draft emerge this summer. #cannabisnews #marijuanamoment #herbsofeden #herbsofedencbd #legalizeit https://lnkd.in/dqBPbnVS

Impending Reclassification: A Game-Changer "The #cannabis industry, long mired in legal and financial uncertainties, is now in a lead position to transform the world of investments, entrepreneurship, and the holistic health industry. "With the Biden administration's move to reclassify cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act, a seismic shift for cannabis investors is on the horizon." Continue below to learn more about this dynamic investment opportunity expanding across the U.S.: https://lnkd.in/e85wzEhJ #dealstream #blog #michigan #professionals #experts #businessbroker #loopnet #bizbuysell #valuation #selling #michiganbusiness #businessowners #capital #realestate #strategy #negotiation #value #creation #capitalbusinessbrokerage #cbb

Vicente has a great article explaining why everyone should temper their expectations around Schedule III. The biggest benefit is removal of 280E, which will be huge for cannabis businesses. But other than that, most of how we all operate will stay pretty much the same. Not to mention, it could still be a long time before Schedule III is official. Good read!

🌿Historic Call for Cannabis Reform: A Game-Changer for Entrepreneurs? 🌿 In a bold move, a group of Democratic senators, including Senator Bernie Sanders, have urged the Biden administration to completely remove marijuana from the Controlled Substances Act, aiming to rectify the extensive community harm inflicted under the current scheduling. This request highlights the drug's disproven classification as a Schedule I substance and underscores its potential medical benefits and lower risk profile. With nearly half of U.S. states embracing recreational marijuana use, the call for legalization has never been stronger. https://bit.ly/47ZY28R This monumental shift presents a unique window of opportunity for entrepreneurs. 📍 Franchise Opportunity Alert with Cannabis10x: Join the Green Revolution! 🚀 The cannabis and CBD sector is witnessing unprecedented growth, offering fertile ground for innovative business models and franchise opportunities. Are you ready to be at the forefront of this transformative period? Whether you're a seasoned entrepreneur or looking to make your mark in a thriving industry, now is the time to act. 📩 Dive into the dynamic world of cannabis by reaching out for more information. Drop a message in the comments or DM us for personalized details on how you can join this exciting journey and capitalize on the green revolution! #CannabisReform #Entrepreneurship #FranchiseOpportunities #Cannabis10x #GreenRevolution Cannabis10X - Buy-Sell | Invest | Franchise

Love this comment on why cannabis prohibition has failed: "Marijuana, as a commodity for production, has unique attributes that distinguish it from alcohol and tobacco. It is relatively easy to grow and does not require industrial processing. Marijuana can be produced anywhere by just about anyone. It is grown throughout the country, in backyards, closets, attics, basements, and warehouses. While little technology is needed to grow marijuana, ample technology to maximize production and yield are widely, legally, available. This is a considerable factor in why prohibition has failed to control the production of marijuana. This will also be a considerable factor in the success or failure of any alternative regulatory regime." -- Jon Gettman & Michael Kennedy  https://lnkd.in/gYyTU97B

European Cannabis Firms Eye Higher IPOs in the US Amid Rescheduling A growing number of European cannabis startups are considering initial public offerings (IPOs) in the United States, anticipating higher valuations in New York compared to London-based exchanges. This move hinges on the Biden administration's efforts to reschedule marijuana, according to the Financial Times and Euro News. Currently, U.S. law prohibits American cannabis companies from listing on major American stock exchanges. However, Canadian operators, where marijuana is federally legal, like Canopy Growth Corp. (CGC) and SNDL, are allowed to list on the Nasdaq. English and Portuguese Companies Interested England-based medical cannabis operator Grow Group has raised 12 million pounds (about $15.6 million) since its inception in 2017. The company previously declined to go public on the London Stock Exchange due to lukewarm investor interest. Now, with potential rescheduling in the U.S., CEO Benjamin Langly told the Financial Times he believes Grow Group can go public on the Nasdaq in early 2025 with a valuation of 100 million pounds. Similarly, Portugal-based cannabis exporter Somai Pharmaceuticals is eyeing a Nasdaq IPO, targeting a valuation of 250 million euros (approximately $273 million), CEO Michael Sassano told the FT. Recategorization Could Influence Exchanges: The U.S. Drug Enforcement The administration proposed moving marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act in May. Rescheduling is expected to make risk-averse stock exchanges and banks more open to engaging with the cannabis industry. Executives emphasize the importance of convincing investors that U.S.-based stock exchanges can avoid the boom-and-bust cycles experienced by cannabis companies currently listed in Canada, such as Canopy Growth and Tilray Brands, which have lost significant value since peaking shortly after Canada legalized recreational cannabis in 2018. Despite similar cycles, U.S.-based firms listed on Canadian exchanges have maintained value as more states move to regulate cannabis. #CannabisIndustry #IPO #USStockMarket #EuropeanStartups #CannabisRescheduling #Nasdaq #InvestmentOpportunities #CannabisBusiness #FinancialGrowth

🌿 Exciting News! 🌿 2024 is shaping up to be a historic year for cannabis legalization across the United States. Find out which states are paving the way for a greener future. 🌱🗳️ Read the full article here: https://lnkd.in/gMWZm9XZ Stay informed, stay engaged, and let's keep pushing for progress in cannabis reform. 🌍💚 #CannabisLegalization #CannabisNews #ProgressiveChange #digitalmarketing #cannabismarketing

New York regulators on Friday awarded 110 new adult-use marijuana business licenses. However, the yearslong struggle to launch what was promised to be a multibillion-dollar market is poised to continue. The state Cannabis Control Board on Friday voted to award: 24 cultivation licenses. 9 distribution licenses. 26 microbusiness licenses. 12 processor licenses. 25 retail licenses. 14 provisional retail licenses. It’s unclear how quickly the licensed businesses will be able to start operations. The 110 new licensees represent only a fraction of the entrepreneurs attempting to enter the market. During a six-week window in the fall, the Office of Cannabis Management (OCM)  received more than 2,100 license applications. #newyorkcannabisbusinesses #newyorkcannabisicenses #cannabis #cannabisindustry #cultivationlicense #cannabisretaillicenses  https://lnkd.in/gHYqky6v

🚀 The Cannabis Industry: Navigating Change, Growth, and Global Trends 🌿 The landscape of the cannabis industry is undergoing transformative shifts, with regulatory changes and market dynamics playing crucial roles. Here are some key points driving this evolution: 1. **Regulatory Changes**: The wave of legalizing recreational cannabis in states across the U.S. is a landmark shift powered by strong public approval and states seeking new revenue streams. This regulatory evolution is reshaping the industry's foundations. 🌐#Regulation #CannabisPolicy 2. **Market Growth**: The cannabis market is on an upward trajectory, fueled by the burgeoning legal markets and diversification in product offerings such as edibles, vapes, and more. This growth opens doors for innovative products and new consumer bases. 📈#MarketGrowth #Innovation 3. **Investment and Mergers**: Increased investments and significant mergers are spotlighting the cannabis sector. These capital inflows and acquisitions are setting the stage for industry consolidation and maturity. 💹#Investment #Mergers 4. **International Developments**: Countries like Canada and Mexico are setting precedents in cannabis legalization, influencing global market dynamics and regulations. These international strides could serve as templates for other nations considering similar legislation. 🌍#GlobalTrends #RegulatoryInfluence 5. **Challenges and Opportunities**: While regulatory obstacles, tax implications, and a scarcity of comprehensive research present challenges, they also underscore vast opportunities for innovation, research, and growth. The potential for advancements in cannabis-related studies and product development remains immense. ⚖️#Challenges #Opportunities The rapid progression of the cannabis industry presents a dynamic blend of opportunities and hurdles. It's a thrilling time to be part of this evolving sector, where every challenge can lead to groundbreaking innovations and growth. Let's foster a dialogue on navigating these changes and harnessing the opportunities. Share your insights or experiences in the comments. How do you see these trends shaping the future of cannabis? 🚀💬 #CannabisIndustry #RegulatoryChanges #MarketGrowth #Investment #GlobalCannabis #Innovation #IndustryTrends